酵母细胞类型特异性抑制剂α2与非细胞类型特异性蛋白合作作用
C A Keleher1, C Goutte, A D Johnson
1Department of Biochemistry and Biophysics, University of California, San Francisco 94143.
Cell
|June 17, 1988
概括
一种新型蛋白质GRM与酵母α2抑制剂合作结合. 这种对基因抑制至关重要的相互作用涉及GRM结合操作中心和α2二极体结合其末端.
科学领域:
- 分子生物学分子生物学
- 酵母遗传学 酵母遗传学
- 转录条例 转录条例 转录条例
背景情况:
- 酵母α2蛋白作为细胞类型特定的转录抑制剂起作用.
- 阿尔法2蛋白通过与目标基因上游的特定操作符序列结合来发挥其功能.
研究的目的:
- 确定和描述一种与酵母α2蛋白相互作用的新型蛋白质.
- 阐明合作结合的机制及其在转录抑制中的作用.
主要方法:
- 使用酵母遗传学的蛋白质-蛋白质相互作用研究.
- 对突变操作者的分析,以确定DNA识别序列.
- 在体内使用试验促进剂进行抑制测试.
主要成果:
- 确定了一种新型蛋白质,称为GRM,它与α2合作结合.
- GRM 结合了操作器的中心,而α 2 双元结合了操作器的末端,创造了一个独特的蛋白质排列.
- 无论是GRM还是α2识别序列,都对 vivo 中的抑制至关重要.
结论:
- GRM和α2在操作者表现出合作结合,由蛋白质-蛋白质相互作用介导.
- 阿尔法2的N端域参与了与GRM的合作结合.
- 这种相互作用对于由GRM/alpha 2复合体介导的转录抑制至关重要.
更多相关视频
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
09:27Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability
Published on: April 22, 2016
相关概念视频
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
